AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Cryptococcal Infection with Ruxolitinib in Primary Myelofibrosis: A Case Report and Literature Review
  • +2
  • Zachary Ciochetto,
  • Njeri Wainaina,
  • Anna Corey,
  • Mary Beth Graham,
  • Muhammad Bilal Abid
Zachary Ciochetto
Medical College of Wisconsin

Corresponding Author:[email protected]

Author Profile
Njeri Wainaina
Medical College of Wisconsin
Author Profile
Anna Corey
Medical College of Wisconsin
Author Profile
Mary Beth Graham
Medical College of Wisconsin
Author Profile
Muhammad Bilal Abid
Medical College of Wisconsin
Author Profile

Abstract

Cryptococcus neoformans (CN) is an encapsulated yeast that causes disseminated and potentially life-threatening in immunocompromised hosts. We present a patient with primary myelofibrosis on ruxolitinib who developed disseminated disease due to CN. The report underscores the importance of suspecting infections with intracellular pathogens in immunosuppressed patients on ruxolitinib.

Peer review status:Published

03 Dec 2021Submitted to Clinical Case Reports
Show details
Hide details
04 Dec 2021Submission Checks Completed
04 Dec 2021Assigned to Editor
09 Dec 2021Reviewer(s) Assigned
24 Dec 2021Review(s) Completed, Editorial Evaluation Pending
24 Dec 2021Editorial Decision: Revise Minor
06 Jan 20221st Revision Received
06 Jan 2022Submission Checks Completed
06 Jan 2022Assigned to Editor
06 Jan 2022Review(s) Completed, Editorial Evaluation Pending
17 Jan 2022Editorial Decision: Revise Minor
24 Jan 20222nd Revision Received
25 Jan 2022Submission Checks Completed
25 Jan 2022Assigned to Editor
25 Jan 2022Review(s) Completed, Editorial Evaluation Pending
06 Feb 2022Editorial Decision: Accept
Feb 2022Published in Clinical Case Reports volume 10 issue 2. 10.1002/ccr3.5461